Can Dexrazoxane and Carvedilol prevent Doxorubicin-induced nephrotoxicity?
Jarosław Szponar(Medical University of Lublin), Sławomir Mańdziuk(Medical University of Lublin), Marta Ostrowska-Leśko(Medical University of Lublin), Bartosz Wielgomas(Gdańsk Medical University), Agnieszka Gorska(Medical University of Lublin)
Cited by 2
Related Papers
ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer
|Annals of Oncology|2020|164
Apigenin and hesperidin augment the toxic effect of doxorubicin against HepG2 cells
|BMC Pharmacology and Toxicology|2019|61
Inhibition of glycolysis disrupts cellular antioxidant defense and sensitizes HepG2 cells to doxorubicin treatment
|FEBS Open Bio|2019|50
The effect of a number of H9C2 rat cardiomyocytes passage on repeatability of cytotoxicity study results
|Cytotechnology|2016|48
The Role of Molecular and Inflammatory Indicators in the Assessment of Cognitive Dysfunction in a Mouse Model of Diabetes
|International Journal of Molecular Sciences|2021|43